IL6 and obesity due to melanocortin 4 receptor deficiency: IL-6 knockout mice have been shown to develop impaired glucose tolerance and obesity, which can be partially reversed by the administration of IL-6 [47]; on the other hand, even a 100-fold increase in IL-6 levels during post-absorptive conditions does not appear to affect the rate of change in glucose levels in humans [46].